Cover Image

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab

Saved in:

Bibliographic Details
Main Authors:	Sean J. Igelman, BS (Author), Chanho Na, MD (Author), Eric L. Simpson, MD, MCR (Author)
Format:	Book
Published:	Elsevier, 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
by: Jonathan J. Park, PhD, et al.
Published: (2023)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018)

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis
by: Bethany F. Wilken, MSc, et al.
Published: (2024)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab
by: Kalisa Lum, BS, et al.
Published: (2024)

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature
by: Gabriela Fonseca, BS, et al.
Published: (2024)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Mingxia Wang, et al.
Published: (2022)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Surina Frey, et al.
Published: (2021)

Psoriasis‐like eruptions developed in an atopic dermatitis patient treated with dupilumab
by: Rai Fujimoto, et al.
Published: (2022)

Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitis
by: Mohamed A. Kamal, et al.
Published: (2022)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023)

Peristomal irritant contact dermatitis treated with dupilumab
by: Emma Villamaria, BSA, et al.
Published: (2023)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
by: Leah Laageide, MD, et al.
Published: (2021)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
by: M. Steinhoff, et al.
Published: (2022)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2020)

A Case of Sézary Syndrome in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Kaito Muramatsu, et al.
Published: (2024)

Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab
by: Diana Gruenstein, BA, et al.
Published: (2020)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022)

Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumabCapsule Summary
by: Francesco Bellinato, MD, et al.
Published: (2023)

Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis
by: Hye Sung Han, et al.
Published: (2023)

Effectiveness of tacrolimus ointment on facial lesions refractory to topical corticosteroid in patients with atopic dermatitis receiving dupilumab
by: Hideaki Uchida, et al.
Published: (2022)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
by: Deng L, et al.
Published: (2022)

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
by: Liu L, et al.
Published: (2023)

Atopic dermatitis in 32 children treated with dupilumab in real life. A new contribution
by: Isabel Betlloch‐Mas, et al.
Published: (2024)

Fragmented Facial Flushing: A Quiz
by: Alexis B. Lyons, et al.
Published: (2024)

An infant with a unilateral facial flush
by: Michelle Shi, et al.
Published: (2023)

Impact of Alcohol-Induced Facial Flushing Phenotype on Alcohol Consumption Among Korean Adults: 2-Year Cross-Sectional Study
by: Bossng Kang, et al.
Published: (2024)

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023)

Dupilumab normalizes correlates of lysosomal function in atopic dermatitis
by: Christina Bürgler, et al.
Published: (2024)